Acino International AG is a Swiss pharmaceutical company headquartered in Zurich, focused on developing, manufacturing, and internationally commercializing well-proven and innovative pharmaceuticals in novel drug delivery forms. They specialize in advanced drug delivery technologies and provide high-quality generics and value-added medicines in key therapeutic areas such as gastroenterology, cardiovascular, and pain relief. Acino has a strong presence in emerging markets across the Middle East, Africa, the CIS Region, and Latin America, aiming to provide affordable healthcare solutions and improve patient access to essential medicines.
The Zurich headquarters serves as the central hub for global strategic decision-making, corporate governance, finance, business development, global marketing, and human resources.
The office is situated in a modern business park, likely featuring contemporary office design focused on collaboration and efficiency. Proximity to Zurich Airport enhances international connectivity.
The work culture at Acino's HQ likely emphasizes Swiss precision, quality, innovation, patient-centricity, and a collaborative international environment, reflecting its global operations.
The Zurich HQ is significant as it anchors Acino in the reputable Swiss pharmaceutical landscape, leverages Switzerland's stable economic environment, and drives the company's global expansion strategy.
Acino supports a wide range of functions globally including research and development, manufacturing (e.g., Liesberg, Switzerland), quality assurance, supply chain management, commercial operations (sales & marketing), regulatory affairs, and business development. Their primary market focus is on emerging markets in the Middle East, Africa, the CIS region, and Latin America, with commercial offices and partners in many of these countries.
Thurgauerstrasse 36/38
Zürich
Zürich
Switzerland
Address: Dubai Science Park, North Tower, Office 1001, P.O. Box 500767, Dubai, UAE (Example, verify specific current address)
To drive growth and expand patient access to Acino's portfolio of affordable, high-quality medicines across the strategically important MEA region.
Address: Acino Asia Pte Ltd, (Verify specific address in Singapore)
To establish and grow Acino's presence in key Asian markets, adapting its offerings to local healthcare needs and regulatory landscapes.
Address: Acino Pharma AG Representative Office (Verify specific address in Kyiv)
To ensure continued supply and access to essential medicines in Ukraine and the CIS region, supporting local healthcare systems.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Acino' leadership includes:
Acino has been backed by several prominent investors over the years, including:
Acino has seen strategic appointments to strengthen its leadership team, particularly in commercial and technical operations, reflecting its growth ambitions.
Discover the tools Acino uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Acino commonly uses the 'first.last' or 'firstinitiallast' email format. Variations might exist, but these are the most prevalent for corporate communications.
[first].[last]@acino.swiss or [f][last]@acino.swiss
Format
john.doe@acino.swiss
Example
85%
Success rate
Acino Press Release • September 12, 2023
Acino and Pharmax, a UAE-based branded generic pharmaceutical company, announced the expansion of their existing licensing and supply agreement. This strategic move aims to enhance patient access to affordable, high-quality medicines in the UAE, focusing on cardiovascular and gastrointestinal treatments....more
Acino Press Release • October 4, 2023
Acino announced the appointment of Eva Kopecna as its new Chief Commercial Officer (CCO), effective October 2023. Kopecna brings over 20 years of experience in the pharmaceutical industry and will be responsible for leading Acino's global commercial strategy and operations....more
Acino Press Release • February 22, 2024
Acino and Servier announced a new partnership in South Africa. Acino will take over the sales, marketing, and distribution of a portfolio of Servier’s original and generic medicines for cardiology, diabetes, and neuropsychiatry, enhancing access for patients in the region....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Acino, are just a search away.